Corporate bond action in Europe continued on Friday as Boston Scientific Corp raised €1.5bn, pleasing bankers who had looked forward to a good crop of Reverse Yankee deals this month to make up for ...
Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Boston Scientific Corp. grew its headcount by 5,000 and its real estate footprint by more than 1 million square feet in 2024.
Zacks.com on MSN1d
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...
In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...
Boston Scientific Corp. recently received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview mapping software to be used with its Farapulse pulsed field ablation (PFA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback